Showing results (1-10 of 183) with videos related to
Sort By:
Pageof 19
AIDS Reviews|January 16, 2007
Switching strategies to improve lipid profile and morphologic changesPatricia Barragan, Cesar Fisac, Daniel PodzamczerExpert Opinion on Pharmacotherapy|August 20, 2008
Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatmentPatricia Barragan, Daniel PodzamczerThe Journal of Clinical Endocrinology and Metabolism|November 7, 2003
A comparison of the effects of nevirapine and nelfinavir on metabolism and body habitus in antiretroviral-naive human immunodeficiency virus-infected patients: a randomized controlled studyCesar Fisac, Nuria Virgili, Elena Ferrer, et al.AIDS (London, England)|May 21, 2005
Metabolic benefits 24 months after replacing a protease inhibitor with abacavir, efavirenz or nevirapineCesar Fisac, Emilio Fumero, Manuel Crespo, et al.AIDS Reviews|November 7, 2013
Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapineDaniel PodzamczerAIDS Reviews|December 22, 2012
The role of rilpivirine in clinical practice: strengths and weaknesses of the new nonnucleoside reverse transcriptase inhibitor for HIV therapyArkaitz Imaz, Daniel PodzamczerEnfermedades Infecciosas Y Microbiologia Clinica|April 11, 2015
[Mechanisms of action, pharmacology and interactions of dolutegravir]Esteban Ribera, Daniel PodzamczerExpert Review of Clinical Pharmacology|January 30, 2019
Switching strategies in the recent era of antiretroviral therapyPaula Prieto, Daniel PodzamczerExpert Review of Anti-Infective Therapy|January 25, 2017
Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIVArkaitz Imaz, Daniel PodzamczerExpert Opinion on Drug Metabolism & Toxicology|July 27, 2006
A review of nelfinavir for the treatment of HIV infectionMontserrat Olmo, Daniel PodzamczerPageof 19